PharmaEssentia Corporation (TPE:6446)

Taiwan · Delayed Price · Currency is TWD

649.00

+6.00 (0.93%)

Mar 27, 2026, 9:20 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development of New Drugs	15.63B	9.73B	5.11B	2.88B	656.51M
Research and Development of New Drugs Growth	60.61%	90.67%	77.15%	339.00%	17.81%
Total	15.63B	9.73B	5.11B	2.88B	656.51M
Total Growth	60.61%	90.67%	77.15%	339.00%	17.81%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
America	11.97B	7.58B	4.50B	1.93B	72.37M
America Growth	57.90%	68.28%	133.23%	2568.61%	-
Europe	1.87B	1.00B	147.71M	613.83M	205.24M
Europe Growth	86.24%	578.60%	-75.94%	199.08%	-23.67%
Asia (Excluding Taiwan)	1.40B	784.85M	131.31M	30.29M	35.92M
Asia (Excluding Taiwan) Growth	78.88%	497.71%	333.46%	-15.65%	476.58%
Taiwan	395.12M	367.63M	322.08M	306.60M	342.98M
Taiwan Growth	7.48%	14.14%	5.05%	-10.61%	21.56%
Total	15.63B	9.73B	5.11B	2.88B	656.51M
Total Growth	60.61%	90.67%	77.15%	339.00%	17.81%

Source: S&P Global Market Intelligence.